[The main intervention studies (clinical trials) in type-2 diabetes: implications for primary care].
Méndola
J
J
Asesor médico, Novartis Farmacéutica, SA. josep.mendola@pharma.novartis.com
Mediavilla Bravo
J
J
D001786:Blood Glucose / Q000187:drug effects / Q000378:metabolism; D002986:Clinical Trials as Topic; D003920:Diabetes Mellitus / Q000453:epidemiology; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy* / Q000453:epidemiology; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D009765:Obesity; D019518:Postprandial Period; D011320:Primary Health Care
D001786:Blood Glucose; D007004:Hypoglycemic Agents